These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 21357741)

  • 1. Liver-expressed Igkappa superantigen induces tolerance of polyclonal B cells by clonal deletion not kappa to lambda receptor editing.
    Ota T; Ota M; Duong BH; Gavin AL; Nemazee D
    J Exp Med; 2011 Mar; 208(3):617-29. PubMed ID: 21357741
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of cell:cell competition and BAFF expression on peripheral B cell tolerance and B-1 cell survival in transgenic mice expressing a low level of Igkappa-reactive macroself antigen.
    Aït-Azzouzene D; Gavin AL; Skog P; Duong B; Nemazee D
    Eur J Immunol; 2006 Apr; 36(4):985-96. PubMed ID: 16511898
    [TBL] [Abstract][Full Text] [Related]  

  • 3. B cell deletion, anergy, and receptor editing in "knock in" mice targeted with a germline-encoded or somatically mutated anti-DNA heavy chain.
    Pewzner-Jung Y; Friedmann D; Sonoda E; Jung S; Rajewsky K; Eilat D
    J Immunol; 1998 Nov; 161(9):4634-45. PubMed ID: 9794392
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vivo VL-targeted activation-induced apoptotic supraclonal deletion by a microbial B cell toxin.
    Goodyear CS; Narita M; Silverman GJ
    J Immunol; 2004 Mar; 172(5):2870-7. PubMed ID: 14978088
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An immunoglobulin C kappa-reactive single chain antibody fusion protein induces tolerance through receptor editing in a normal polyclonal immune system.
    Ait-Azzouzene D; Verkoczy L; Peters J; Gavin A; Skog P; Vela JL; Nemazee D
    J Exp Med; 2005 Mar; 201(5):817-28. PubMed ID: 15738053
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enforced Bcl-2 expression inhibits antigen-mediated clonal elimination of peripheral B cells in an antigen dose-dependent manner and promotes receptor editing in autoreactive, immature B cells.
    Lang J; Arnold B; Hammerling G; Harris AW; Korsmeyer S; Russell D; Strasser A; Nemazee D
    J Exp Med; 1997 Nov; 186(9):1513-22. PubMed ID: 9348309
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Split tolerance in peripheral B cell subsets in mice expressing a low level of Igkappa-reactive ligand.
    Aït-Azzouzene D; Verkoczy L; Duong B; Skog P; Gavin AL; Nemazee D
    J Immunol; 2006 Jan; 176(2):939-48. PubMed ID: 16393979
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Negative selection by IgM superantigen defines a B cell central tolerance compartment and reveals mutations allowing escape.
    Duong BH; Ota T; Aoki-Ota M; Cooper AB; Ait-Azzouzene D; Vela JL; Gavin AL; Nemazee D
    J Immunol; 2011 Dec; 187(11):5596-605. PubMed ID: 22043016
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Kappa editing rescues autoreactive B cells destined for deletion in mice transgenic for a dual specific anti-laminin Ig.
    Brady GF; Congdon KL; Clark AG; Sackey FN; Rudolph EH; Radic MZ; Foster MH
    J Immunol; 2004 May; 172(9):5313-21. PubMed ID: 15100270
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Light chain editing in kappa-deficient animals: a potential mechanism of B cell tolerance.
    Prak EL; Trounstine M; Huszar D; Weigert M
    J Exp Med; 1994 Nov; 180(5):1805-15. PubMed ID: 7964462
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peripheral B cell tolerance and function in transgenic mice expressing an IgD superantigen.
    Duong BH; Ota T; Aït-Azzouzene D; Aoki-Ota M; Vela JL; Huber C; Walsh K; Gavin AL; Nemazee D
    J Immunol; 2010 Apr; 184(8):4143-58. PubMed ID: 20231687
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Receptor editing and genetic variability in human autoreactive B cells.
    Lang J; Ota T; Kelly M; Strauch P; Freed BM; Torres RM; Nemazee D; Pelanda R
    J Exp Med; 2016 Jan; 213(1):93-108. PubMed ID: 26694971
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting Anti-Insulin B Cell Receptors Improves Receptor Editing in Type 1 Diabetes-Prone Mice.
    Bonami RH; Thomas JW
    J Immunol; 2015 Nov; 195(10):4730-41. PubMed ID: 26432895
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Surrogate light chain expression beyond the pre-B cell stage promotes tolerance in a dose-dependent fashion.
    Kil LP; Corneth OB; de Bruijn MJ; Asmawidjaja PS; Krause A; Lubberts E; van Loo PF; Hendriks RW
    J Autoimmun; 2015 Feb; 57():30-41. PubMed ID: 25523463
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exogenous superantigens acutely trigger distinct levels of peripheral T cell tolerance/immunosuppression: dose-response relationship.
    Miethke T; Wahl C; Gaus H; Heeg K; Wagner H
    Eur J Immunol; 1994 Aug; 24(8):1893-902. PubMed ID: 8056049
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD4 regulates the efficiency of an endogenous superantigen-induced clonal deletion of TCRV beta 11+ cells in the periphery.
    Kubo S; Hasegawa A; Hashimoto K; Shimizu C; Kubo M; Tada T; Nakayama T
    Immunology; 1997 Dec; 92(4):437-46. PubMed ID: 9497484
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ig light chain receptor editing in anergic B cells.
    Tze LE; Baness EA; Hippen KL; Behrens TW
    J Immunol; 2000 Dec; 165(12):6796-802. PubMed ID: 11120801
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The efficiency of B cell receptor (BCR) editing is dependent on BCR light chain rearrangement status.
    Yachimovich N; Mostoslavsky G; Yarkoni Y; Verbovetski I; Eilat D
    Eur J Immunol; 2002 Apr; 32(4):1164-74. PubMed ID: 11932924
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rearrangement of mouse immunoglobulin kappa deleting element recombining sequence promotes immune tolerance and lambda B cell production.
    Vela JL; Aït-Azzouzene D; Duong BH; Ota T; Nemazee D
    Immunity; 2008 Feb; 28(2):161-70. PubMed ID: 18261939
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Death by a B cell superantigen: In vivo VH-targeted apoptotic supraclonal B cell deletion by a Staphylococcal Toxin.
    Goodyear CS; Silverman GJ
    J Exp Med; 2003 May; 197(9):1125-39. PubMed ID: 12719481
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.